Pinned
European Society of Cardiology
33.8K posts
European Society of Cardiology
@escardio
European Society of Cardiology. Join us also on @ESC_Journals @ESCAdvocacy @ESCardioNews @ESC_President. #ESCCongress #ESCGuidelines #ESCTVToday #ESCDigital
- .@escardio does not endorse the unfortunate personal post by one of its social media ambassadors. Diego Araiza has publicly apologised and will no longer be an ambassador for the society, as his message infringed ESC social media guidelines.
- #ADVOR trial: acetazolamide added to intravenous loop diuretics decreases congestion within 3 days in patients with acute decompensated #heartfailure. #ESCCongress
- #DELIVER trial: dapagliflozin reduces the risk of #cardiovascular death or worsening #heartfailure in HF patients with mildly reduced and preserved ejection fraction. #ESCCongress
- ESC 2020 Guidelines for non-ST elevation acute coronary syndrome just released bit.ly/3lsC8Ux #ESCCongress #ESCGuidelines #cardiotwitter #MedTwitter
- #SECURE trial: polypill containing aspirin, atorvastatin and ramipril leads to clinically relevant reductions in recurrent #cardiovascular events in post-myocardial infarction patients. #ESCCongress
- #Semaglutide improves heart failure-related symptoms and physical function and results in greater weight loss compared with placebo in patients with #HFpEF and #obesity ⬇️ #ESCCongress STEP-HFpEF trial
- Share your technology or innovation with the cardiac community. Two great opportunities to present your digital health solutions during ESC Congress / ESC Digital Summit 2019. Submit by 28 June bit.ly/2weJu5K
00:00 - #TIME trial: randomised trial in more than 21,000 patients with high blood pressure has concluded that protection against heart attack, stroke and vascular death is not affected by whether antihypertensive medications are taken in the morning or evening. #ESCCongress
- NEW: 2023 #ESCGuidelines for the management of #AcuteCoronarySyndromes 👉escardio.org/Guidelines/Cli… #ACS #medtwitter #ESCCongress
- Statin use is associated with lower risk of stroke in patients with #AtrialFibrillation ⬇️ #EHRA2023 #afib #EPeeps #EHRA_ESC
- JUST RELEASED: 2019 #ESGuidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases - what's new? what has changed? what are the main 2019 recommendations? bit.ly/329WGXE #ESCCongress #cardiotwitter
- #REVIVED trial: Percutaneous coronary intervention does not reduce all-cause mortality or #heartfailure hospitalisation in patients with severe left ventricular dysfunction and extensive #coronary artery disease. #ESCCongress
- #INVICTUS trial: VKA reduce #cardiovascular events and mortality, without increasing major bleeding, compared to rivaroxaban in patients with rheumatic heart disease and #atrialfibrillation. #ESCCongress
